Cisplatin reduces Brucella melitensis-infected cell number by inducing apoptosis, oxidant and pro-inflammatory cytokine production

Research in Veterinary Science

Volumn 88, Issue 2, 2010, Pages 218-226

  Erdogan, Suat ^a   Tosyali, Eda ^a   Duzguner, Vesile ^a   Kucukgul, Altug ^a   Aslantas, Ozkan ^a   Celik, Sefa ^a  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Brucella melitensis; Cisplatin; Inflammation; Nitric oxide

Indexed keywords

ACETYLCYSTEINE; CISPLATIN; GLUTATHIONE PEROXIDASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; MYELOPEROXIDASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; XANTHINE OXIDASE;

APOPTOSIS; ARTICLE; BRUCELLA MELITENSIS; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOPATHOGENIC EFFECT; DNA FRAGMENTATION; DOWN REGULATION; DRUG CYTOTOXICITY; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; INTRACELLULAR BACTERIUM; MACROPHAGE; NONHUMAN; OXIDATIVE STRESS;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BRUCELLA MELITENSIS; CISPLATIN; CYTOKINES; DNA FRAGMENTATION; GENE EXPRESSION REGULATION; HUMANS; MACROPHAGES; OXIDANTS; U937 CELLS;

ANIMALIA; BRUCELLA; BRUCELLA MELITENSIS;

EID: 76849095168     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rvsc.2009.09.002     Document Type: Article

References (38)

1. Baldwin C.L., and Parent M. Fundamentals of host immune response against Brucella abortus: what the mouse model has revealed about control of infection. Veterinary Microbiology 90 (2002) 367-382
2. Barry M.A., Behnke C.A., and Eastman A. Activation of apoptosis by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochemical Pharmacology 40 (1990) 2353-2362
3. Billard E., Dornand J., and Gross A. Brucella suis prevent human dendritic cell maturation and antigen presentation through the regulation of TNF-α secretion. Infection and Immunity 75 (2007) 4980-4989
4. Bragado P., Armesilla A., Silva A., and Porras A. Apoptosis by cisplatin requires p53 mediated p38alpha MAPK activation through ROS generation. Apoptosis 12 (2007) 1733-1742
5. Brune B., Mohr S., and Messmer U.K. Protein thiol modification and apoptotic cell death as cGMP-independent nitric oxide (NO) signaling pathways. Reviews of Physiology, Biochemistry and Pharmacology 127 (1996) 1-30
6. Caron E., Peyrard T., Kohler S., Cabane S., Liautard J.P., and Dornand J. Live Brucella spp. fail to induce tumor necrosis factor alpha excretion upon infection of U937-derived phagocytes. Infection and Immunity 62 (1994) 5267-5274
7. Celli J. Surviving inside a macrophage: the many ways of Brucella. Research in Microbiology 57 (2006) 93-98
8. Corbel M.J. Brucellosis: an overview. Emerging Infectious Diseases 3 (1997) 213-221
9. Cortas N.K., and Wakid N.W. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clinical Chemistry 36 (1990) 1440-1443
10. Erdogan S., Aslantas O., Celik S., and Atik E. The effects of increased cAMP content on inflammation, oxidative stress and PDE4 transcripts during Brucella melitensis infection. Research in Veterinary Science 84 (2008) 18-25
11. Giaccone G. Clinical perspectives on platinum resistance. Drugs 59 Suppl. 4 (2000) 9-17 (discussion, 37-38)
12. Giambartolomei G.H., Delpino M.V., Cahanovich M.E., Wallach J.C., Baldi P.C., Velikovsky C.A., and Fossati C.A. Diminished production of T helper 1 cytokines correlates with T cell unresponsiveness to Brucella cytoplasmic proteins in chronic human brucellosis. The Journal of Infectious Disease 186 (2002) 252-259
13. Gross A., Spiesser S., Terraza A., Rouot B., Caron E., and Dornand J. Expression and bactericidal activity of nitric oxide synthase in Brucella suis-infected murine macrophages. Infection and Immunity 66 (1998) 1309-1316
14. Gross A., Terraza A., Ouahrani-Bettache S., Liautard J.P., and Dornand J. In vitro Brucella suis infection prevents the programmed cell death of human monocytic cells. Infection and Immunity 68 (2000) 342-351
15. Gross A., Bertholet S., Mauel J., and Dornand J. Impairment of Brucella growth in human macrophagic cells that produce nitric oxide. Microbial Pathogenesis 36 (2004) 75-82
16. Hansen M.B., Nielsen S.E., and Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. Journal of Immunology Methods 119 (1989) 203-210
17. He Y., Reichow S., Ramamoorthy S., Ding X., Lathigra R., Craig J.C., Sobral B.W., Schurig G.G., Sriranganathan N., and Boyle S.M. Brucella melitensis triggers time-dependent modulation of apoptosis and down-regulation of mitochondrion-associated gene expression in mouse macrophages. Infection and Immunity 74 (2006) 5035-5046
18. Jain A., Winkel B.S., and Brewer K.J. In vivo inhibition of E. coli growth by a Ru(II)/Pt(II) supramolecule [(tpy)RuCl(dpp)PtCl2](PF6). Journal of Inorganic Biochemistry 101 (2007) 1525-1528
19. Jimenez de Bagües M.P., Gross A., Terraza A., and Dornand J. Regulation of the mitogen-activated protein kinases by Brucella spp. expressing a smooth and rough phenotype: relationship to pathogen invasiveness. Infection and Immunity 73 (2005) 3178-3183
20. Kariminia A., Kavoossy G., Khatami S., Zowghi E., and Ardestani S.K. Study of interleukin-10 and interleukin-12 productions in response to lipopolysaccharides extracted from two different Brucella strains. Comparative Immunology, Microbiology and Infectious Diseases 25 (2002) 85-93
21. Kim Y.K., Kim H.J., Kwon C.H., Kim J.H., Woo J.S., Jung J.S., and Kim J.M. Role of ERK activation in cisplatin-induced apoptosis in OK renal epithelial cells. Journal of Applied Toxicology 25 (2005) 374-382
22. Ko J., and Splitter G.A. Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans. Clinical Microbiology Reviews 16 (2003) 65-78
23. Lapaque N., Moriyon I., Moreno E., and Gorvel J.P. Brucella lipopolysaccharide acts as a virulence factor. Current Opinion in Microbiology 8 (2005) 60-66
24. Lieberthal W., Triaca V., and Levine J. Mechanisms of death induced by cisplatin in proximal tubular epithelial cell: apoptosis vs. necrosis. The American Journal of Physiology 270 (1996) 700-708
25. Luck H. Catalase. In: Bergmeyer H.U. (Ed). Methods of Enzymatic Analysis (1965), Chemie, Weinheim, Germany 885-894
26. Maliakel D.M., Kagiya T.V., and Nair C.K. Prevention of cisplatin-induced nephrotoxicity by glucosides of ascorbic acid and alpha-tocopherol. Experimental Pathology 60 (2008) 521-527
27. Melino G., Catani M.V., Corazzari M., Guerrieri P., and Bernassola F. Nitric oxide can inhibit apoptosis or switch it into necrosis. Cellular and Molecular Life Sciences 57 (2000) 612-622
28. Mishima K., Baba A., Matsuo M., Itoh Y., and Oishi R. Protective effect of cyclic AMP against cisplatin-induced nephrotoxicity. Free Radical Biology and Medicine 40 (2006) 1564-1577
29. Morel Y., and Barouki R. Repression of gene expression by oxidative stress. Biochemical Journal 342 (1999) 481-496
30. Pahan K., Sheikh F.G., Namboodiri A.M., and Singh I. N-acetyl cysteine inhibits induction of no production by endotoxin or cytokine stimulated rat peritoneal macrophages, C6 glial cells and astrocytes. Free Radical Biology and Medicine 24 (1998) 39-48
31. Prajda N., and Weber G. Malignant transformation-linked imbalance: decreased XO activity in hepatomas. FEBS Letters 59 (1975) 245-249
32. Rafiei A., Ardestani S.K., Kariminia A., Keyhani A., Mohraz M., and Amirkhani A. Dominant Th1 cytokine production in early onset of human brucellosis followed by switching towards Th2 along prolongation of disease. Journal of Infection 53 (2006) 315-324
33. Ramesh G., and Reeves W.B. p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice. American Journal of Physiology. Renal Physiology 289 (2005) F166-F174
34. Solera J., Espinosa A., Martínez-Alfaro E., Sánchez L., Geijo P., Navarro E., Escribano J., and Fernández J.A. Treatment of human brucellosis with doxycycline and gentamicin. Antimicrobial Agents and Chemotherapy 41 (1997) 80-84
35. Suzuki K., Ota H., Sasagawa S., Sakatani T., and Fujikura T. Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Analytical Biochemistry 132 (1983) 345-352
36. Wada T., and Penninger J.M. Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23 (2004) 2838-2849
37. Wang X., Martindale J.L., and Holbrook N.J. Requirement for ERK activation in cisplatin-induced apoptosis. Journal of Biological Chemistry 275 (2000) 39435-39443
38. Wang M., Qureshi N., Soeurt N., and Splitter G. High levels of nitric oxide production decrease early but increase late survival of Brucella abortus in macrophages. Microbial Pathogenesis 31 (2001) 221-230